| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $476.2M | +13.3% |
| Cost of Revenue | $275.2M | +13.2% |
| Gross Profit | $201.0M | +13.3% |
| R&D Expense | $2.9M | +0.0% |
| SG&A Expense | $87.2M | +15.7% |
| Operating Income | $62.6M | +5.9% |
| Pre-tax Income | $64.1M | +12.8% |
| Income Tax | $12.5M | +10.5% |
| Net Income | $51.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.9M | +130.3% |
| Accounts Receivable | $49.8M | +71.0% |
| Inventory | $122.8M | +10.7% |
| Current Assets | $230.7M | +37.0% |
| Total Assets | $382.5M | +33.9% |
| Current Liabilities | $71.0M | +71.0% |
| Total Liabilities | $97.3M | +61.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $66.9M | +40.0% |
| Capital Expenditures | $4.0M | -40.3% |
| Investing Cash Flow | -$33.8M | -83.5% |
| Financing Cash Flow | -$3.7M | +81.0% |
| Free Cash Flow | $62.9M | +53.1% |
| +12.6% |
| EPS (Basic) | $1.85 | +12.1% |
| EPS (Diluted) | $1.85 | +12.1% |
| Stockholders' Equity |
| $280.3M |
| +24.3% |